2016 ASCO Annual Meeting

Transcription

1 UNIVERSITY OF CHICAGO PRESENTATIONS THURSDAY JUNE 2 1:00 pm-2:50 pm The Economics of Cancer Care Seminar Session I: Innovative Cancer Treatment Models: Theory, Evidence and Practice Outpatient Oncology Consolidation Effects on Prices and Quality of Care Presenter: Rena Conti* 1:00 pm-2:50 pm How to Integrate Tumor Immunotherapy Into Your Clinical Practice Seminar Session I: The Immune System and Cancer Basic Principles of Tumor Immunology Presenter: Justin Kline* Location: S100bc 3:10 pm-5:00 pm The Economics of Cancer Care Seminar Session II: Innovative Cancer Care Models in Practice Chair & Moderator: Rena Conti* 3:35 pm-5:00 pm New Drugs in Oncology Seminar Session III: Drug Development: How Far We ve Come Post-Treatment Biopsies in Phase I Clinical Trials: Counterpoint Presenter: Randy Sweis Location: S100a FRIDAY JUNE 3 10:00 am-11:00 am The Economics of Cancer Care Seminar Session IV: MACRA Panel Discussion: Where Do We Go From Here? Moderator: Rena Conti* 1:40 pm-2:00 pm Current Understanding and Research Initiatives in Neuroblastoma Survivorship Speaker: Tara Henderson* 2:20 pm-2:40 pm Pathways in Payment Reform Speaker: Blase Polite* Type: Extended Education Session Location: E450ab 5:12 pm-5:24 pm Phase 1/2 study of carfilzomib, pomalidomide, and dexamethasone (KPd) in patients (Pts) with relapsed/refractory multiple myeloma (RRMM): A Multiple Myeloma Research Consortium multicenter study Presenter: Cara Rosenbaum Location: E354b

2 SATURDAY JUNE 4 7:30 am-7:40 am Optimize Your Experience Presenter: Jyoti Patel Location: S501 8:00 am-8:20 am Ethical Frameworks for Approaching Germline Genetic Testing and Disclosure in Pediatrics Speaker: Lainie Ross 8:00 am-11:30 am KRAS gene amplification to define a distinct molecular subgroup of gastroesophageal adenocarcinoma Presenter: David Xu Type: Poster Session (Board #57) 8:00 am-11:30 am Validating a PET/CT volumetric prognostic index for non-small cell lung cancer Presenter: Yonglin Pu* Type: Poster Session (Board #144) 8:00 am-11:30 am Peri-operative modified FOLFIRINOX in resectable pancreatic cancer: A pilot study Presenter: Qin Zhang Type: Poster Session (Board #95) 8:00 am-11:30 am Molecular characterization of immune exclusion in small-cell lung cancer Presenter: Sope Omowale Olugbile Type: Poster Session (Board #193) 8:55 am-9:10 am Utilizing Existing Resources to Intervene Upon Geriatric Assessment- Detected Vulnerabilities Among Older Adults Speaker: William Dale* Type: Extended Education Session Location: S103 1:00 pm-4:30 pm A phase I/II trial of enzalutamide plus the glucocorticoid receptor antagonist mifepristone for patients with metastatic castration resistant prostate cancer (mcrpc) Presenter: Russell Szmulewitz* Type: Poster Session (Board #439a) 1:00 pm-4:30 pm Randomized phase 2 trial of cediranib alone or cediranib plus lenalidomide in iodine 131-refractory differentiated thyroid cancer (DTC): A University of Chicago Phase 2 Consortium trial Presenter: Jonas De Souza* Type: Poster Session (Board #335)

3 SATURDAY JUNE 4 1:00 pm-4:30 pm A phase 3, randomized, open-label study of first-line durvalumab (MEDI4736) ± tremelimumab versus standard of care (SoC; EXTREME regimen) in recurrent/metastatic (R/M) SCCHN: KESTREL Presenter: Tanguy Seiwert* Type: Poster Session (Board #423a) 1:00 pm-4:30 pm State mandated insurance benefits and off-label use of cancer drugs Presenter: Fabrice Smieliauskas* Type: Poster Session (Board #23) 1:00 pm-4:30 pm Implementing the patient reported outcomes measurement information system (PROMIS) global health scale in the adolescent and young adult (AYA) oncology population Presenter: Joseph Henderson Type: Poster Session (Board #52) 1:15 pm-2:30 pm Lung Cancer Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers Session Co-Chair: Thomas Hensing Type: Poster Discussion Session 1:55 pm-2:15 pm The Danger of Death-With-Dignity Program Presenter: Daniel Sulmasy Location: S100bc 2:27 pm-2:39 pm WNT/β-catenin pathway activation correlates with immune exclusion across most human cancers Presenter: Jason Luke* Location: Hall B1 3:00 pm-4:15 pm Women in Oncology: A Roundtable Discussion on Professional Development Speaker: Sonali Smith* Location: S406 3:20 pm-3:40 pm Endoscopic Ultrasound for Staging of Rectal Cancer Speaker: Irving Waxman* Type: Meet the Professor Session Location: E253D 3:20 pm-3:40 pm Merit-Based Incentive Payment System (MIPS) and Alternative Payment Models (APMs) Speaker: Blase Polite* Location: S100bc 3:24 pm-3:36 pm Evolving Standards in Myeloid Malignancies Discussant: Richard Larson*

4 SATURDAY JUNE 4 5:39 pm-5:51 pm Choosing Wisely: Value in Drug Cost Discussant: Rena Conti* Type: Poster Discussion Session Location: S404 SUNDAY JUNE 5 8:00 am-11:30 am A model to predict axillary nodal pathologic complete response following neoadjuvant chemotherapy for breast cancer Presenter: Olga Kantor Type: Poster Session (Board #152) 8:00 am-11:30 am NRG BR002: A phase IIR/III trial of standard of care therapy with or without stereotactic body radiotherapy (SBRT) and/or surgical ablation for newly oligometastatic breast cancer Presenter: Steven Chmura* Type: Poster Session (Board #202a) 8:46 am-8:58 am Tremelimumab as second- or third-line treatment of unresectable malignant mesothelioma (MM): Results from the global, double-blind, placebo-controlled DETERMINE study Presenter: Hedy Kindler* 9:36 am-9:48 am Balancing the Risk/Benefit Ratio of Cisplatin-Based Therapies Discussant: Mark Ratain* 10:05 am-10:25 am The Case for a Pediatric-like Regimen Speaker: Wendy Stock* Type: Meet the Professor Session Location: E253D 10:21 am-10:33 am Treatment of Rare Lymphoid Malignancies Discussant: Sonali Smith* Location: E354b 10:45 am-10:57 am Clonal Hematopoiesis and How It Can Confound the Results of Somatic and Germline Genetic Testing Discussant: Olatoyosi Odenike* Type: Clinical Science Symposium Location: S404 11:30 am-12:15 pm Neuroblastoma: Advances Through Collaboration Award Lecturer: Susan Cohn* Type: Award Lecture 4:45 pm-4:57 pm Considering Rational PD-1/PD-L1 Combinations Discussant: Thomas Gajewski* Type: Poster Discussion Session Location: Hall B1

5 MONDAY JUNE 6 8:00 am-9:30 am Individualizing Care for the Older Patient: From Immunotherapy to Surgery Session Co-Chair: Andrew Artz* Type: Clinical Science Symposium 8:00 am-11:30 am Feasibility of early withdrawal of immunosuppression (WOI) followed by dose escalation of prophylactic donor lymphocyte infusion (pdli) after T-cell depleted (TCD) matched donor allogeneic hematopoietic cell transplantation (HCT) Presenter: Hongtao Liu* Type: Poster Session (Board #42) 8:00 am-11:30 am Economic evaluation of carfilzomib + lenalidomide + dexamethasone (KRd) vs. lenalidomide + dexamethasone (Rd) in relapsed or refractory multiple myeloma (R/RMM) Presenter: Andrzej J. Jakubowiak* Type: Poster Session (Board #286) 8:00 am-11:30 am Second malignancies in patients with neuroblastoma: A report from the International Neuroblastoma Risk Group Project Presenter: Mark Applebaum Type: Poster Session (Board #238) 8:00 am-11:30 am Computer-assisted Curie scoring for metaiodobenzylguanidine (mibg) scans in patients with neuroblastoma Presenter: Elizabeth Sokol Type: Poster Session (Board #250) 9:36 am-9:48 am Quality of life (QOL) analysis from CHAARTED: Chemohormonal androgen ablation randomized trial in prostate cancer (E3805) Presenter: Linda Patrick-Miller Location: Hall D2 10:05 am-10:25 am Why Burnout Is Important and Identifying Burnout in Healthcare Providers Speaker: Fay Hlubocky 11:30 am-12:45 pm Metastatic Melanoma: Making the Right Treatment Choices Moderator: Jason Luke* Location: E450ab 11:48 am-12:00 pm Long-term Results in Myeloproliferative Neoplasms and Myelodysplastic Syndromes Discussant: Olatoyosi Odenike* Type: Poster Discussion Session Location: E354b

6 MONDAY JUNE 6 12:21 pm-12:33 pm Managing Patient and Provider Financial Toxicity Discussant: Jonas De Souza* Location: S100a 1:00 pm-4:30 pm Genome wide association study of cisplatin-induced peripheral neuropathy (CIPN) in testicular cancer survivors Presenter: Omar El Charif Type: Poster Session (Board #165) 1:00 pm-4:30 pm Glucocorticoid receptor expression and survival in ovarian cancer Presenter: Jennifer Veneris Type: Poster Session (Board #368) 1:00 pm-4:30 pm Death anxiety, psychological distress, and quality of life (QOL) in adolescent and young adult (AYA) cancer patients with hematologic malignancies in early survivorship Presenter: Fay Hlubocky Type: Poster Session (Board #61) 4:45 pm-4:57 pm Treatment Beyond Progression: Forward Progress or Simply Progression Confirmed? Discussant: Walter Stadler* Type: Poster Discussion Session SUNDAY JUNE 7 8:00 am-11:00 am Cancer Prevention, Hereditary Genetics, and Epidemiology Session Co-Chair: Habibul Ahsan* CONTACT US The University of Chicago Medicine Comprehensive 5841 South Maryland Ave, MC 1140, H212, Chicago, IL feedback@bsd.uchicago.edu